DexCom

YTD

ALL

Trade DexCom 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DXCM

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE.

CEO

Jacob S. Leach

CEOJacob S. Leach

Employees

11,100

Employees11,100

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1999

Founded1999

Employees

11,100

Employees11,100

DXCM Key Statistics

Market cap

25.90B

Market cap25.90B

Price-Earnings ratio

32.22

Price-Earnings ratio32.22

Dividend yield

—

Dividend yield—

Average volume

4.34M

Average volume4.34M

High today

$68.05

High today$68.05

Low today

$66.71

Low today$66.71

Open price

$66.72

Open price$66.72

Volume

748.24K

Volume748.24K

52 Week high

$89.98

52 Week high$89.98

52 Week low

$54.11

52 Week low$54.11

Stock Snapshot

The current DexCom(DXCM) stock price is $67.31, with a market capitalization of 25.9B. The stock trades at a price-to-earnings (P/E) ratio of 32.22.

During the trading session on 2026-03-18, DexCom(DXCM) shares reached a daily high of $68.05 and a low of $66.71. At a current price of $67.31, the stock is +0.9% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 748.24K, compared to an average daily volume of 4.34M.

Over the past 52 weeks, DexCom(DXCM) stock has traded between a high of $89.98 and a low of $54.11.

DXCM News

Simply Wall St 4d

Assessing DexCom Valuation As Conference Highlights Growth In Glucose Monitoring Technology

Advertisement Conference spotlight and why DexCom (DXCM) is on investor radars DexCom (DXCM) is in focus as it presents new clinical findings and product upda...

Simply Wall St 7d

Is DexCom Quietly Reframing Its Innovation Moat With New Boardroom Tech Expertise?

DexCom, Inc. recently announced that long-time leader Kevin R. Sayer has returned from a temporary leave to resume his role as Executive Chairman, while Rick Os...

Analyst ratings

82%

of 33 ratings

Buy

81.8%

Hold

15.2%

Sell

People also own

Based on the portfolios of people who own DXCM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.